Impact of telemedicine on glycemic control in type 2 diabetes mellitus during the COVID-19 lockdown period

• Published in: Frontiers in endocrinology (Lausanne) Vol. 14; p. 1068018
• Main Authors: Al-Mutairi, Abrar M, Alshabeeb, Mohammad A, Abohelaika, Salah, Alomar, Fadhel A, Bidasee, Keshore R
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 03.02.2023
• Subjects: Blood Glucose; Communicable Disease Control; COVID-19; diabetes mellitus; Diabetes Mellitus, Type 2 - drug therapy; Endocrinology; Female; Glycated Hemoglobin; glycated hemoglobin A1c; Glycemic Control; Humans; Hypertension; lockdown; Male; Middle Aged; Telemedicine; COVID-19; lockdown; telemedicine; diabetes mellitus; glycated hemoglobin A1c

The lockdown at the start of coronavirus disease 2019 (COVID-19) pandemic in Saudi Arabia (March 2020 to June 2020) shifted routine in-person care for patients with type 2 diabetes mellitus (T2DM) to telemedicine. The aim of this study was to investigate the impact telemedicine had during this perio...